Idexx Laboratories
IDXX
319 hedge funds and large institutions have $5.62B invested in Idexx Laboratories in 2014 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 122 reducing their positions, and 25 closing their positions.
64% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 25
4% more funds holding
Funds holding: 306 → 319 (+13)
14% less capital invested
Capital invested by funds: $6.51B → $5.62B (-$884M)
21% less repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 122
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.16M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$193M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$42.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.1M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$25.4M |
| 5 |
GAM
Gotham Asset Management
New York
|
+$19.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$226M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$77.7M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$61.9M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$49.1M |
| 5 |
CCI
Columbus Circle Investors
|
-$33.2M |
IDXX Hedge Fund Activity: Q3 2014 in Review
319 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2014, worth a combined $5.62B — down 14% from $6.51B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new IDXX positions and 25 closed out — a net gain of 16 holders — while 96 added to existing stakes and 122 trimmed.
The largest buyer was Select Equity Group, opening a new position worth an estimated $193M. The largest seller was T. Rowe Price Associates, cutting an estimated $226M.
- 319 institutional investors held Idexx Laboratories (IDXX) as of Q3 2014, up from 306 in Q2 2014.
- Funds reported $5.62B of Idexx Laboratories stock for Q3 2014, down 14% quarter-over-quarter.
- 41 funds opened new Idexx Laboratories positions in Q3 2014 and 25 closed out, a net change of +16 holders.
- The largest Idexx Laboratories buyer in Q3 2014 was Select Equity Group, an estimated $193M added.
- The largest Idexx Laboratories seller in Q3 2014 was T. Rowe Price Associates, an estimated $226M sold.
Based on aggregated 13F filings for Q3 2014.